GLP-1 without the brand app
Semaglutide and tirzepatide change four signals at once. Here is how to read them yourself, with AI, instead of trusting the prescriber's dashboard.
GLP-1 receptor agonists — semaglutide, tirzepatide, and the rest — have arrived in mainstream wellness faster than the measurement habits to use them well. Most users watch one number, weight, and miss the more interesting story their body is telling.
The medication is doing several things at once. Appetite. Gastric emptying. Glucose response. Body composition. Energy. Mood. Side effects. Treating that as a single number is like reading a novel and only counting the pages.
what the trial evidence actually shows
For weight loss in people with obesity, the evidence is strong: semaglutide and tirzepatide produce clinically meaningful losses across 68- and 72-week trials [meta-analysis, n=4,200]. For glycaemic control in type 2 diabetes, also strong (Lancet, 2024). For cardiovascular outcomes in higher-risk populations, promising and growing (BMJ Open, 2023).
What is less discussed: lean mass loss can be substantial without protein and resistance training; nausea and reflux are common at dose escalation; energy and mood responses are highly individual. None of that shows up in the brand app's progress chart.
why the brand app is not enough
Manufacturer and pharmacy apps are designed to keep you compliant with the prescription. They are not designed to help you understand your own response. They rarely connect dose, food, training, sleep, and side effects in one place. They almost never let you export.
the four signals worth tracking
- Body composition — weight is the slow trend; waist and any DEXA or impedance reading is the truth.
- Glycaemic markers — fasting glucose, post-prandial response if you have a CGM, HbA1c every 3 months.
- Side effects — daily 1–10 score for nausea, reflux, fatigue, and constipation; note when they spike around dose changes.
- Behaviour and capacity — protein intake, training sessions, sleep duration, mood. The medication makes these easier to ignore until it doesn't.
the 3-Layer treatment, applied
- Research model — get a sourced, calm view of what the medication does and doesn't do, separated from the marketing language and the influencer panic.
- Ledger model — one place: weekly dose, weight, waist, fasting glucose, daily protein, training sessions, side effect scores, sleep, mood. Yours. Exportable.
- Protocol model — short single-variable tests on the things that actually move outcomes: protein floor, resistance training frequency, eating window, hydration. AI designs the test; you and your prescriber judge it.
where the line is
Dose decisions, escalation, contraindications, and stopping rules belong with a prescriber. AI is excellent at between-visit pattern recognition and at preparing you for the conversation. It is not, and should never be, the prescriber. The course explicitly draws this line.
Used this way, a GLP-1 stops being a prescription you take and becomes a protocol you understand. Same medication, different relationship to your own body — and to the system around it.
Recommended next